Depression is a massive hurdle for many people. Some people find that their usual treatment plans don't work for them.  This is called treatment resistant depression (TRD).

        For those with TRD, things like daily tasks and work can become a major struggle. A recent study compared two different treatments, esketamine nasal spray (NS) and quetiapine extended release (XR), to see which one helped more with daily functioning and work productivity.

        The study, which lasted 32 weeks, had over 600 participants. Everyone was already taking an SSRI or SNRI, which are common antidepressants. The key question was which treatment would bring better results in terms of functionality and productivity.

        The Sheehan Disability Scale (SDS) was used to measure how well people could function in daily life. The goal was to see if people could reach functional remission, which means their score on the SDS was 6 or lower.

        Another important factor was how much work and daily activities were affected. This was measured using the Work Productivity and Activity Impairment: Depression (WPAI:D) questionnaire. The results were tracked over the entire study period.

        The study found that those who used esketamine NS had 43. 2% more weeks with functional remission compared to those who used quetiapine XR. This difference was statistically significant, meaning it was likely not due to chance.

        When it came to work productivity, esketamine NS users had a 14. 2% reduction in overall work productivity loss. This was a big deal because it showed that esketamine NS might be a better option for those struggling with TRD.

        The study also looked at how much time was lost due to absenteeism, which is when someone misses work. Esketamine NS users had a smaller reduction in productivity loss due to absenteeism, but this difference was not statistically significant.

        The results suggest that esketamine NS might be a more effective treatment for those with TRD. It could lead to better daily functioning and work productivity, which are crucial for overall well-being.

        This study provides hope for those who have not found success with traditional treatments. However, it's important to note that everyone's experience with depression is unique. What works for one person might not work for another.

        The study highlights the importance of finding the right treatment for each individual. It also shows that there are options available for those who have not found relief with standard treatments.

A New Hope for Depression Sufferers

Actions